{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0007256,73,MONDO:0007256,123,1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0007256","source":"MONDO:0007256|hepatocellular carcinoma","targets":["NCT00168987|Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors|COMPLETED|PHASE4|INTERVENTIONAL","NCT00365508|Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking|COMPLETED|PHASE4|INTERVENTIONAL","NCT00494312|Safety Study of Pioglitazone Compared To Glyburide on Liver Function|COMPLETED|PHASE4|INTERVENTIONAL","NCT00510627|Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00554905|Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00555334|Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00556803|TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00557024|Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00646100|Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00666978|Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking|COMPLETED|PHASE4|INTERVENTIONAL","NCT00768157|Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00834860|Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01098760|Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT01102335|Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01203787|Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01298284|A Trial of EVL\\GVS Alone vs. EVL\\GVS Combined Propranolol|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01332669|Drug-eluting Bead in Hepatocellular Carcinoma|COMPLETED|PHASE4|INTERVENTIONAL","NCT01351194|Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01409499|Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01415063|Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01438437|Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01451658|A Trial of EVL\\GVS Alone vs. EVL\\GVS Combined Propranolol (S-HCC)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01570075|Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01575574|Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT01639703|Hepatic Xenetix-CT Perfusion|COMPLETED|PHASE4|INTERVENTIONAL","NCT01798160|Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).|COMPLETED|PHASE4|INTERVENTIONAL","NCT01806740|DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC|TERMINATED|PHASE4|INTERVENTIONAL","NCT01849588|HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)|TERMINATED|PHASE4|INTERVENTIONAL","NCT01894269|Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01970748|Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01997957|A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02174575|Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT02253511|A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02321202|Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT02399033|Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02472249|Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC|COMPLETED|PHASE4|INTERVENTIONAL","NCT02504983|Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02525380|Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02534961|Prophylactic Antibiotics Before RFA for HCC|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02535117|Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02729506|Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02733809|Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02785380|Laparoscopic Surgery VS RFA for Recurrent HCC|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT02853500|Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT02933333|G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02959359|DAA in the Risk of Recurrence After Curative Treatment of HCC|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT02961998|Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail|COMPLETED|PHASE4|INTERVENTIONAL","NCT03007212|Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT03007225|Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT03024684|Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT03151213|Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver|COMPLETED|PHASE4|INTERVENTIONAL","NCT03212625|The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction|COMPLETED|PHASE4|INTERVENTIONAL","NCT03215355|Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT03515369|Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03518502|Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03843229|Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03963206|Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)|COMPLETED|PHASE4|INTERVENTIONAL","NCT03996681|TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04015245|SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT04032860|RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT04288323|Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis|COMPLETED|PHASE4|INTERVENTIONAL","NCT04562428|The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial|COMPLETED|PHASE4|INTERVENTIONAL","NCT04569799|Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE|COMPLETED|PHASE4|INTERVENTIONAL","NCT04653818|HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial|COMPLETED|PHASE4|INTERVENTIONAL","NCT04707547|Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT04731558|Pre- Vs Postoperative Thromboprophylaxis for Liver Resection|RECRUITING|PHASE4|INTERVENTIONAL","NCT04769713|Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05022628|Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05113290|Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05185505|Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria|RECRUITING|PHASE4|INTERVENTIONAL","NCT05331911|Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors|RECRUITING|PHASE4|INTERVENTIONAL","NCT05416073|Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05670561|Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05717400|Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy|TERMINATED|PHASE4|INTERVENTIONAL","NCT05926336|The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action|RECRUITING|PHASE4|INTERVENTIONAL","NCT06041425|The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE|COMPLETED|PHASE4|INTERVENTIONAL","NCT06084234|National Liver Cancer Screening Trial|RECRUITING|PHASE4|INTERVENTIONAL","NCT06173466|Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone|COMPLETED|PHASE4|INTERVENTIONAL","NCT06311916|Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT06311929|Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma|RECRUITING|PHASE4|INTERVENTIONAL","NCT06311942|Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.|RECRUITING|PHASE4|INTERVENTIONAL","NCT06353126|DEB-TACE Prior to Liver Transplantation in the Treatment of HCC|RECRUITING|PHASE4|INTERVENTIONAL","NCT06464380|Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT06594744|Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC|RECRUITING|PHASE4|INTERVENTIONAL","NCT06717919|HOPE Against Cancer Recurrence in HCC|RECRUITING|PHASE4|INTERVENTIONAL","NCT06923176|Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT06930573|A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk|RECRUITING|PHASE4|INTERVENTIONAL","NCT07059494|Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant|RECRUITING|PHASE4|INTERVENTIONAL","NCT07150624|The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine|RECRUITING|PHASE4|INTERVENTIONAL","NCT00003424|Tamoxifen in Treating Patients With Primary Liver Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003912|Chemotherapy in Treating Children With Liver Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00012324|Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00027768|Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00041275|Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT00057382|T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00079027|Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00109954|Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT00149565|Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00151671|Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00165633|A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL"]}]}